Description
Metformin Hydrochloride Prolonged-Release and Glimepiride 2mg + 500mg Tablets are an effective oral antidiabetic combination designed to help manage blood glucose levels in adults with Type 2 diabetes. Metformin supports controlled and sustained glucose regulation by reducing hepatic glucose production, while Glimepiride assists the pancreas in increasing insulin release. Together, they work to improve glycemic control when diet and exercise alone are insufficient.
Offered under PCD Pharma Distributorship, this product provides profitable business opportunities with strong market demand, reliable formulation quality, and consistent patient preference, making it a valuable addition to any diabetes-care range. Fortune Labs provides more PCD franchise exchanges. Making Pharma Distributorship easier and more feasible for you.
Key Components of Metformin 500mg, Glimepiride 2mg Tablets
Glimepiride (2mg): As a sulfonylurea, glimepiride stimulates the beta cells in the pancreas to release more insulin. Insulin helps remove sugar from the blood and move it into cells.
Metformin Hydrochloride: Metformin is a biguanide that works in three main ways:
- It decreases the amount of glucose the liver produces.
- It delays the absorption of sugar from the intestines.
- It improves the body’s sensitivity to insulin, which helps the body’s cells use glucose more effectively.
Uses of Metformin 500mg and Glimepiride 2mg Tablets
Controlling blood sugar in type 2 diabetes: This combination medicine helps manage blood glucose levels, both during fasting and after meals.
Improving insulin sensitivity: Metformin enhances the body’s response to insulin, helping your cells use glucose more effectively.
Increasing insulin release: Glimepiride stimulates the pancreas to produce more insulin, which helps move sugar from the blood into your cells.
Preventing diabetes complications: By maintaining healthy blood sugar levels, this medication reduces the risk of serious complications, including kidney damage, nerve problems, and eye issues.
Supporting cardiovascular health: Effective blood sugar control can lower the risk of heart-related issues like high blood pressure and blocked arteries that are common in people with diabetes
Partner with Fortune Labs for PCD Franchise with 500mg Glimepiride 2mg Tablets
Fortune Labs-with all the latest molecules and continuously progressing under the table guidance of our Managing Experts.
- We provide a wide range of formulations such as tablets, injections, and new drugs that are DCGI-approved.
- These include Analgesics, Antibiotics & Anti-Infectives, Anticolds & Anti Allergics, and Antipsychotic Drugs.
- Apart from these, our range also includes Cardiovascular Drugs, gastroenteric and antiemetic/antiulcerant medications, Hematirics, Hormones, Neurology Supplements, and Nutritional Supplements.
- Our entire range also encompasses Table Syrup, Protesachetschet, Dry Powder, Capsules, Injectables, Ointment, Eye & Ear / Nasal Drops, and Yurvedic Products. Manufactured as per WHO GMP norms, Quality is Own Prime Concern; these are assured to have high-quality standards. This firm is a sister concern of Prosperity Six Pharmaceuticals (ISO 9001:2008, WHO, GMP)
Some Common Side Effects of Metformin 500mg Glimepiride 2mg Tablets
- Stomach upset: Includes nausea, vomiting, stomach pain, and diarrhea.
- Metallic taste: A temporary, unpleasant metallic taste in the mouth may occur.
- Headache
- Upper respiratory tract infection
- Weight gain: Glimepiride, one of the components, can contribute to weight gain
Frequently Asked Questions
What are these tablets used for?
A: The combination of Metformin (prolonged-release) and Glimepiride (2 mg) is used to treat Type 2 Diabetes Mellitus (T2DM). The two drugs work via complementary mechanisms: Glimepiride stimulates the pancreas to release more insulin, while Metformin reduces glucose production in the liver and improves insulin sensitivity.
Q: How does the prolonged-release (PR) formulation help?
A: The PR formulation of Metformin ensures a gradual and sustained release of the drug, which helps maintain stable blood glucose levels throughout the day and can reduce gastrointestinal side effects compared with immediate-release formulations.
Q: When and how should the tablet be taken?
A: Typically, the tablet is taken with meals, often once daily with breakfast or the first main meal. Sometimes, depending on the doctor’s advice, it may be prescribed twice daily. The tablet should be swallowed whole, not crushed or chewed, with a glass of water.
Q: Is this combination safe for long-term use?
A: Yes, when used under medical supervision, with regular monitoring (especially kidney function), this combination is widely used for long-term management of type 2 diabetes.
Q: What are the most common side effects?
A: Common side effects may include gastrointestinal symptoms (nausea, vomiting, diarrhea, stomach discomfort), headache, or dizziness. Because Glimepiride increases insulin release, there is also a risk of low blood sugar (hypoglycemia), especially if a meal is skipped.
Q: Are there any serious but rare risks or precautions?
A: Yes. For Metformin, there is a rare but serious risk of Lactic Acidosis, especially in people with impaired kidney or liver function, dehydration, severe infections, or conditions causing low oxygen. Also, Glimepiride is not suitable for patients with certain conditions like type 1 diabetes, ketoacidosis, severe renal or hepatic dysfunction.
